POLICY

MichBio works tirelessly for public policy that drives the growth of Michigan's biosciences industry across a variety of market sectors.

As our member companies seek to develop and manufacture sustainable, bio-based food, energy and industrial products, as well as life-changing medical devices, diagnostics, and medicines for the global consumption, MichBio assists their technology innovation and commercialization efforts by advocating for smart and appropriate laws and regulations that guide research, development and go-to-market activities.

STATE POLICY PRIORITIES

MichBio participates in policy efforts that work to create a pro-innovation environment that enables the growth of the life sciences community and the development of treatments and technologies that feed, fuel, and cure the world. Those efforts encompass the following policy priorities for Michigan:

TAKE ACTION

There are many ways you can get involved in the advocacy process including signing or composing letters to policy-makers, attending advocacy-related events, and staying informed on active legislation related to the bio-industry. Your work is important, so is your voice.

BIOSCIENCE LEGISLATIVE CAUCUS

Michigan is one of few states that has a designated legislative caucus for the bio-industry. The Caucus acts as an additional voice for the industry in the State legislature.

PARTNERSHIPS AND TOOLKITS

MichBio is part of a network of organizations that work nationally and internationally on behalf of the United States and global bio-industries. As part of those partnerships, MichBio participates in federal advocacy days, policy-specific advocacy efforts, and engages organizations within the state of Michigan to participate in national advocacy where appropriate.

Given the number of issues across all sectors, MichBio leans on the national organizations to provide information on the current issues at the federal level and tools for advocates specific to the sector they represent. Those national partners are:

The Advanced Medical Technology Association (AdvaMed), is a trade association that leads the effort to advance medical technology in order to achieve healthier lives and healthier economies around the world.

AdvaMed promotes competitive policies that foster the highest ethical standards, rapid product approvals, appropriate reimbursement, and access to international markets. While those policies are tailored to specific issues facing the device and diagnostics industry, the need for strategic government policies is applicable to all high technology, high-value sectors.

The Biotechnology Innovation Organization (BIO) is the world's largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organizations across the United States and in 30+ countries.

As a proactive voice of science and for science, BIO is driving a revolution to cure patients, protect the climate, and nourish humanity through education and advocacy that unites the industry, removes barriers to innovation, and champions broad access to biotech breakthroughs and scientific equality.

The Medical Device Manufacturers Association (MDMA) is a national trade association based in Washington, DC.

MDMA plays a proactive role in helping to shape policy that impacts the medical device innovator. To achieve these goals, MDMA represents its members' collective interests before the United States Congress, the Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS), and other federal agencies that develop or implement policies that affect the medical device industry.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives.

Since 2000, PhRMA member companies have invested nearly $1 trillion in the search for new treatments and cures, including an estimated $83 billion in 2019 alone.

MichBio also collaborates with CropLife America, Healthcare Distribution & Management Association (HDMA), Medical Imaging & Technology Alliance (MITA), National Venture Capital Association (NVCA), Regenerative Medicine Foundation, Research America, We Work for Health, and the almost 60 state medical technology and biotech associations.